← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 21, 2022Last known activity
Oct 28, 2025
Timeline
2010s
- Jan 1, 2019
SpyGlass Pharma, Inc.— Founded
Drugs by trial phase (2 distinct, 4 trials)
Phase 3 (2 own, 0 via acquisition)
Recent trials (8)
- NCT07218796OfficialPhase 3Oct 28, 2025
- NCT07218796Lead sponsorPhase 3Oct 28, 2025
- NCT07218783OfficialPhase 3Oct 15, 2025
- NCT07218783Lead sponsorPhase 3Oct 15, 2025
- NCT06120842Lead sponsorPhase 1/Phase 2Oct 13, 2023
- NCT06120842Study chairPhase 1/Phase 2Oct 13, 2023
- NCT07154797Lead sponsorN/AApr 21, 2022
- NCT07154797OfficialN/AApr 21, 2022
Details
- Founded
- Aliso Viejo, CA, US Jan 1, 2019
- Last known activity
- Oct 28, 2025